These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38378887)

  • 1. Temporal and topological properties of dynamic networks reflect disability in patients with neuromyelitis optica spectrum disorders.
    Wang Y; Yang Z; Zheng X; Liang X; Chen J; He T; Zhu Y; Wu L; Huang M; Zhang N; Zhou F
    Sci Rep; 2024 Feb; 14(1):4199. PubMed ID: 38378887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In patients with mild disability NMOSD: is the alteration in the cortical morphological or functional network topological properties more significant.
    Ma H; Zhu Y; Liang X; Wu L; Wang Y; Li X; Qian L; Cheung GL; Zhou F
    Front Immunol; 2024; 15():1345843. PubMed ID: 38375481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disrupted structural network of inferomedial temporal regions in relapsing-remitting multiple sclerosis compared with neuromyelitis optica spectrum disorder.
    Cho EB; Kim D; Jeong B; Shin JH; Chung YH; Kim ST; Kim BJ; Han CE; Min JH
    Sci Rep; 2022 Mar; 12(1):5152. PubMed ID: 35338192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
    J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD).
    Bigaut K; Achard S; Hemmert C; Baloglu S; Kremer L; Collongues N; De Sèze J; Kremer S
    PLoS One; 2019; 14(1):e0211465. PubMed ID: 30695058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered structural networks in neuromyelitis optica spectrum disorder related with cognition impairment and clinical features.
    Zheng Q; Chen X; Xie M; Fu J; Han Y; Wang J; Zeng C; Li Y
    Mult Scler Relat Disord; 2021 Feb; 48():102714. PubMed ID: 33422915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered functional connectivity associated with cognitive impairment in neuromyelitis optica spectrum disorder.
    Yang Y; Rui Q; Wu X; Chen X; Han S; Yang Y; Wang X; Wu P; Dai H; Xue Q; Li Y
    Mult Scler Relat Disord; 2022 Dec; 68():104113. PubMed ID: 35987110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-varying connectivity of the precuneus and its association with cognition and depressive symptoms in neuromyelitis optica: A pilot MRI study.
    Cacciaguerra L; Mistri D; Valsasina P; Martinelli V; Filippi M; Rocca MA
    Mult Scler; 2022 Nov; 28(13):2057-2069. PubMed ID: 35796514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different damage patterns of short-, middle- and long-range connections between patients with relapse-remitting multiple sclerosis and neuromyelitis optica spectrum disorder.
    Chen X; Peng Y; Zheng Q; Luo D; Han Y; Luo Q; Zhu Q; Luo T; Li Y
    Front Immunol; 2022; 13():1007335. PubMed ID: 36532033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irregular degree centrality in neuromyelitis optica spectrum disorder patients with optic neuritis: A resting-state functional magnetic resonance imaging study.
    Wei R; Yan J; Wu H; Meng F; He F; Liu X; Liang H
    Mult Scler Relat Disord; 2022 Mar; 59():103542. PubMed ID: 35091366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of very late-onset neuromyelitis optica spectrum disorder.
    Cai LJ; Zhang Q; Zhang Y; Chen HX; Shi ZY; Du Q; Zhou HY
    Mult Scler Relat Disord; 2020 Nov; 46():102515. PubMed ID: 33032051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age of onset correlates with clinical characteristics and prognostic outcomes in neuromyelitis optica spectrum disorder.
    Hu Y; Sun Q; Yi F; Yao L; Tian Y; Tang H; Luo M; Xie N; Wang Z; Liao X; Zhou L; Xu H; Zhou Y
    Front Immunol; 2022; 13():1056944. PubMed ID: 36569880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Connectivity Alterations in Neuromyelitis Optica Spectrum Disorder : Correlation with Disease Duration and Cognitive Impairment.
    Han Y; Liu Y; Zeng C; Luo Q; Xiong H; Zhang X; Li Y
    Clin Neuroradiol; 2020 Sep; 30(3):559-568. PubMed ID: 31578601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered resting-state functional connectivity density in patients with neuromyelitis optica-spectrum disorders.
    Wang Y; Kwapong WR; Tu Y; Xia Y; Tang J; Miao H; Liu X; Lu Y; Yan Z
    Mult Scler Relat Disord; 2020 Aug; 43():102187. PubMed ID: 32480345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual system damage and network maladaptation are associated with cognitive performance in neuromyelitis optica spectrum disorders.
    Chavarro VS; Bellmann-Strobl J; Zimmermann HG; Scheel M; Chien C; Oertel FC; Weygandt M; Ruprecht K; Paul F; Finke C; Brandt AU
    Mult Scler Relat Disord; 2020 Oct; 45():102406. PubMed ID: 32707533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
    Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar connectome alterations and associated genetic signatures in multiple sclerosis and neuromyelitis optica spectrum disorder.
    Yang Y; Li J; Li T; Li Z; Zhuo Z; Han X; Duan Y; Cao G; Zheng F; Tian D; Wang X; Zhang X; Li K; Zhou F; Huang M; Li Y; Li H; Li Y; Zeng C; Zhang N; Sun J; Yu C; Shi F; Asgher U; Muhlert N; Liu Y; Wang J
    J Transl Med; 2023 May; 21(1):352. PubMed ID: 37245044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White Matter Network Disruption and Cognitive Dysfunction in Neuromyelitis Optica Spectrum Disorder.
    Cho EB; Han CE; Seo SW; Chin J; Shin JH; Cho HJ; Seok JM; Kim ST; Kim BJ; Na DL; Lee KH; Seong JK; Min JH
    Front Neurol; 2018; 9():1104. PubMed ID: 30619061
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin America.
    Carnero Contentti E; López PA; Criniti J; Pettinicchi JP; Cristiano E; Patrucco L; Bribiesca Contreras E; Gómez-Figueroa E; Flores-Rivera J; Correa-Díaz EP; Toral Granda AM; Ortiz Yepez MA; Gualotuña Pachacama WA; Piedra Andrade JS; Galleguillos L; Tkachuk V; Nadur D; Daccach Marques V; Soto de Castillo I; Casas M; Cohen L; Alonso R; Caride A; Lana-Peixoto M; Rojas JI
    Mult Scler Relat Disord; 2023 Apr; 72():104611. PubMed ID: 36907119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.